Article info

Download PDFPDF

Adalimumab concentration-based tapering strategy: as good as the recommended dosage

Authors

  1. Correspondence to Dr Alejandro Balsa, Department of Rheumatology, Health Research Institute (IdiPAZ), Hospital Universitario La Paz, Madrid 28046, Spain; alejandro.balsa{at}salud.madrid.org
View Full Text

Citation

Mulleman D, Balsa A
Adalimumab concentration-based tapering strategy: as good as the recommended dosage

Publication history

  • Received October 31, 2017
  • Revised December 4, 2017
  • Accepted December 10, 2017
  • First published January 6, 2018.
Online issue publication 
March 12, 2018

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.